Benjamin Cottam - Concepedia

Concepedia

Author

Benjamin Cottam

Providence Portland Medical Center

Also Known As

Benjamin Cottam, Benjamin L Cottam, Cottam, Benjamin

45

Publications

1.1K

Citations

11

H-Index

32

Concepts

All Affiliations

Providence Portland Medical Center Oregon Clinic University of Nottingham Oregon Health & Science University

BC

About

Benjamin Cottam is an author at Providence Portland Medical Center specializing in tumor biology, radiation therapy, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	839
2	Immunology	7	7	839
3	Pathology	4	4	427
4	Cell Biology	3	3	202
5	Health Sciences	2	2	362

Benjamin Cottam

×

11

Publications

1.1K

Citations

11

H-Index

	Year	Citations
Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy Kristina H. Young, Jason R. Baird, Talicia Savage, PLoS ONE ImmunologyIdeal TimingImmunotherapyTumor BiologyImmunotherapy Improves Control	2016	308
Radiotherapy Combined with Novel STING-Targeting Oligonucleotides Results in Regression of Established Tumors Jason R. Baird, David J. Friedman, Benjamin Cottam, Cancer Research ImmunologyImmune RegulationPathologyImmunotherapeuticsImmune Cell Therapy	2015	232
A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma Todd S. Crocenzi, Benjamin Cottam, Pippa Newell, Journal for ImmunoTherapy of Cancer	2016	106
Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy Marka R. Crittenden, Jason R. Baird, David J. Friedman, Oncotarget	2016	106
Expression of NF-κB p50 in Tumor Stroma Limits the Control of Tumors by Radiation Therapy Marka R. Crittenden, Benjamin Cottam, Talicia Savage, PLoS ONE ImmunologyImmune RegulationPathologyImmunologic MechanismImmune Cell Therapy	2012	98
Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma Andrew J. Gunderson, Tomoko Yamazaki, Kayla McCarty, PLoS ONE ImmunologyImmunoeditingImmunotherapeuticsImmune Cell TherapyImmunotherapy	2019	65
Programmed cell death‐1 blockade enhances response to stereotactic radiation in an orthotopic murine model of hepatocellular carcinoma David J. Friedman, Jason R. Baird, Kristina H. Young, Hepatology Research	2016	62
TGFβ Inhibition Prior to Hypofractionated Radiation Enhances Efficacy in Preclinical Models Kristina H. Young, Pippa Newell, Benjamin Cottam, Cancer Immunology Research Radiation EffectImmunologyImmunoeditingPathologyImmune Infiltrate	2014	54
The Peripheral Myeloid Expansion Driven by Murine Cancer Progression Is Reversed by Radiation Therapy of the Tumor Marka R. Crittenden, Talicia Savage, Benjamin Cottam, PLoS ONE Hematological MalignancyTumor BiologyCancer ImmunosurveillanceRadiation TherapyMedicine	2013	43
Expression of Arginase I in Myeloid Cells Limits Control of Residual Disease after Radiation Therapy of Tumors in Mice Marka R. Crittenden, Talicia Savage, Benjamin Cottam, Radiation Research ImmunologyImmunotherapyResidual DiseaseEnzyme ArginaseTumor Biology	2014	39

Page 1